Comparison of unilateral spinal anesthesia and epidural anesthesia

Comparison of unilateral spinal anesthesia and epidural anesthesia for unilateral below T10 sensory level surgeries

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016020819771N2

Enrollment

Registered

2016-07-27

Start date

2014-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal and epidural anesthesia. Other complications of surgical and medical care, not elsewhere classified

Interventions

Intervention 1: Group A: After subarachnoid injection in Sitting position, patients are going to supine positions immediately and then Tilt to the surgical site (45 degrees). L2-L3 and L3-L4 space spi

Treatment - Other

Group A: After subarachnoid injection in Sitting position, patients are going to supine positions immediately and then Tilt to the surgical site (45 degrees). L2-L3 and L3-L4 space spinal Quinke G25 p

Group B: Patients receive epidural anesthesia. In Sitting position the epidural catheter is threaded the Tuohy G17 needle through L2-L3 or L3-L4 space. Loss of resistance techniques used to find the s

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:patient satisfactory; Elective unilateral spinal anesthesia or epidural anesthesia for unilateral below T10 sensory level surgeries; ASA Class1-2(American Society of Anesthesiologists) Exclusion criteria: Patient refusal; Patient disability to remain calm in needle puncture; Increasing intra cranial pressure; Skin infection; Hypervolemia; Sensitive to local anesthesia drugs; Peripheral neuropathy; Nervous disorders; Sever hypotension; Cardiovascular disease; Hepatic disorders; Kidney failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: 12 month. Method of measurement: manometer.;Hearth rate. Timepoint: 12 month. Method of measurement: monitoring system.;Arterial saturation oxygen. Timepoint: 12 month. Method of measurement: monitoring system.;Nausea and vomiting. Timepoint: 12 month. Method of measurement: checklist.;Backage. Timepoint: 12 month. Method of measurement: checklist.;Headache. Timepoint: 12 month. Method of measurement: checklist.	—

Measure

Time frame

Blood pressure. Timepoint: 12 month. Method of measurement: manometer.;Hearth rate. Timepoint: 12 month. Method of measurement: monitoring system.;Arterial saturation oxygen. Timepoint: 12 month. Method of measurement: monitoring system.;Nausea and vomiting. Timepoint: 12 month. Method of measurement: checklist.;Backage. Timepoint: 12 month. Method of measurement: checklist.;Headache. Timepoint: 12 month. Method of measurement: checklist.

—

Secondary

Measure	Time frame
Headache. Timepoint: 12month. Method of measurement: checklist.;Hypotension. Timepoint: 12month. Method of measurement: manometer.;Backache. Timepoint: 12month. Method of measurement: checklist.;Nausea and vomiting. Timepoint: 12month. Method of measurement: checklist.;Heart rate. Timepoint: 12month. Method of measurement: manometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Afshin Gholipour

Emam Hospital

dr.motvali@gmail.com+98 11 3336 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026